WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Powerful Universal Search Engine Makes Scientific Research Easy to Find

Details
Research
26 February 2010
Scientists across the world now have access to a powerful new tool not just to present their research, but also to have it discovered by a global audience. No longer do researchers or smaller labs have to worry about their hard work going unnoticed by other scientists, or have to feel restricted to print journals to communicate their ideas.
Read more ...

Breakthrough may lead to anti-stroke vaccine

Details
Research
16 February 2010
EU-funded scientists have discovered that the presence of low levels of a type of antibody in the immune system increases the chance of having a stroke, one of the leading causes of death worldwide.
Read more ...

The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels

Details
Research
10 February 2010
Manhattan ResearchThe Internet has considerably more influence over consumer health decisions and actions than traditional channels like print, TV and radio, according to pharmaceutical and healthcare market research company Manhattan Research's latest report, "Health Influence Mapping: Benchmarking the Influence of Various Sources on Consumer Health Actions."
Read more ...

European Physician Adoption of Advanced Mobile Activities is Increasing

Details
Research
03 February 2010
Manhattan ResearchAs mobile devices become more advanced, European physicians are turning to them for a number of uses in their professional practice, according to a recent study by Manhattan Research. About half of online European physicians check email on their mobile devices while nearly four in ten search on a mobile web browser.
Read more ...

Manhattan Research Releases New Research on DTC's Impact on Pharma Website Visitation

Details
Research
14 January 2010
Manhattan ResearchNuvaRingĀ® and LatisseĀ® are the top pharmaceutical brands in terms of having the highest percentage of overall product website traffic driven by their DTC television advertisements, according to pharmaceutical and healthcare market research company Manhattan Research.
Read more ...

EU-funded researchers gain insights into genetics of lung functioning

Details
Research
05 January 2010
A large-scale study has identified five new genetic loci (points on the genome) associated with the health of the human lung and pulmonary function. Publishing in the latest edition of the journal Nature Genetics, the partly EU-funded researchers explain that their findings shed new light on the molecular basis of lung disease and might lead to better treatment of chronic obstructive pulmonary disease (COPD), asthma and similar conditions.
Read more ...

IBM, Novartis and Vodafone Join Forces to Help Halt Malaria in Africa

Details
Research
15 December 2009
A new solution developed by IBM (NYSE: IBM), Novartis and Vodafone with the Roll Back Malaria Partnership, is helping to save lives using everyday technology to improve the availability of anti-malarial drugs in remote areas of Tanzania. Called "SMS for Life", the initiative uses a combination of mobile phones, SMS (Short Messaging Service) technologies and intuitive web sites to track and manage the supply of Artemisinin-based Combination Therapy (ACT) drugs and Quinine injectables, both of which are key to reducing the number of deaths from malaria.
Read more ...

More Pharma News ...

  1. Manhattan Research Releases Physician Digital Media Planning Guide
  2. Message on the occasion of World AIDS Day
  3. EU-funded researchers use gene therapy to slow brain disease
  4. 85% of Online Europeans Use the Internet for Health Information
  5. International Diabetes Federation drives global action ahead of World Diabetes Day
  6. European Partnership for Action against Cancer
  7. Advanced Semantic Knowledge-Based Bio-Medical Search Solution
  • Start
  • Prev
  • 281
  • 282
  • 283
  • 284
  • 285
  • 286
  • 287
  • 288
  • 289
  • 290
  • Next
  • End

Business & Industry

  • Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
  • BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
  • Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma
  • AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge
  • Pfizer invests $43 billion to battle cancer

Research & Development

  • 'Biohybrid' device could restore function in paralysed limbs
  • Scientists use tardigrade proteins for human health breakthrough
  • DNA treatment could delay paralysis that strikes nearly all patients with ALS
  • Scientists reveal a potential new approach to treating liver cancer
  • Normalizing tumor blood vessels may improve immunotherapy against brain cancer
  • Engineered bacteria find tumors, then alert the authorities
  • First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Research
  4. 'Biohybrid' device could restore function in paralysed limbs

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.